A vaccine developed by Merck is the first shown to be highly effective in preventing human infection with Ebola, according to final results from a clinical trial. Among 5,837 people who received the rVSV-EBOV vaccine in the trial in Guinea in 2015, no Ebola cases were recorded 10 days or more after vaccination, signaling 100 percent protection.
World Health Organization (WHO)
The populations most vulnerable to malaria – pregnant women and children in sub-Saharan Africa – have seen markedly greater access to effective malaria control in recent years, according to a new report.
Chinese officials promised this week that they no longer harvest organs from executed prisoners, and their international medical guests seemed eager to believe them.